Endocrine Abstracts

Background: Long-term insulin therapy is associated with considerable side-effects. Tight control of blood glucose is vital to minimise risk of complications and to maintain quality of life. Insulin pump therapy (or continuous subcutaneous insulin infusion-CSII) can improve glycaemic control without consequent increased episodes of hypoglycaemia. It has been available for many years but it has only recently begun to be a treatment of choice for type 1 diabetes in the UK. CSII ...